Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BLINATUMOMAB vs BOSENTAN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

BLINATUMOMAB vs BOSENTAN: Safety Overview

Metric BLINATUMOMAB BOSENTAN
Total FAERS Reports 9,161 19,581
Deaths Reported 1,664 4,346
Death Rate 18.2% 22.2%
Hospitalizations 2,427 8,862
Average Patient Age 39.7 yrs 52.5 yrs
% Female Patients 46.7% 73.2%
FDA Approval Date N/A Apr 26, 2019
Manufacturer Amgen, Inc Actelion Pharmaceuticals US, Inc.
Route N/A ORAL
Marketing Status Prescription Prescription